Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

847
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
847

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Brain sciences·2026
Same author

Predictors of Mortality and Outcomes in Older Adult Burn Patient Subgroups: A Comparative Meta-analysis of Age, Burn Severity, and Intervention Strategies.

Plastic and reconstructive surgery. Global open·2026
Same author

Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.

Frontiers in public health·2026
Same author

Advanced Research in Neuroprotection.

Biomedicines·2026
Same author

Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

From Dish to Trial: Building Translational Models of ALS.

Cells·2026

Related Experiment Video

Updated: Jul 5, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K

How Early Is Early Multiple Sclerosis?

Sotiria Stavropoulou De Lorenzo1, Christos Bakirtzis1, Natalia Konstantinidou1

  • 1Multiple Sclerosis Center, Second Department of Neurology, School of Medicine, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.

Journal of Clinical Medicine
|January 11, 2024
PubMed
Summary

Early diagnosis of multiple sclerosis (MS) is crucial. This review explores biomarkers for radiologically isolated syndrome (RIS) to identify those progressing to MS before symptoms appear.

Keywords:
RISdisease progressionearly treatmentlaboratory biomarkersmultiple sclerosismultiple sclerosis prodromeneuroimaging biomarkers

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.6K

Related Experiment Videos

Last Updated: Jul 5, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.6K

Area of Science:

  • Neuroimmunology
  • Neurology
  • Biomarker Discovery

Background:

  • Optimizing diagnostic criteria for multiple sclerosis (MS) is key for early and accurate diagnosis.
  • Early MS treatment is linked to slower disease progression and better long-term outcomes.
  • Neuroinflammatory and neurodegenerative processes may precede symptom onset in MS.

Purpose of the Study:

  • To review current research on MS pathology and potential biomarkers for early detection.
  • To identify individuals with radiologically isolated syndrome (RIS) at high risk of progressing to MS.
  • To increase clinician awareness of subclinical MS and emerging biomarkers for future clinical use.

Main Methods:

  • Comprehensive literature review of studies on MS pathology.
  • Analysis of research on laboratory and neuroimaging biomarkers for MS risk stratification.
  • Focus on biomarkers for identifying individuals with RIS who may convert to definite MS.

Main Results:

  • Neuroinflammatory and neurodegenerative processes can occur before MS symptoms manifest.
  • A significant portion of individuals with RIS eventually develop MS.
  • Currently, no approved treatments exist for RIS, highlighting the need for early detection biomarkers.

Conclusions:

  • Accurate biomarkers are essential for identifying individuals with RIS who will progress to MS.
  • Early detection of subclinical MS through biomarkers could enable timely intervention.
  • Further research and validation of biomarkers are needed for clinical application in managing RIS.